AI-generated summary
In APP/PS1 mice modeling Alzheimer's disease, the authors report that 808 nm photobiomodulation for 6 weeks was associated with improved cognitive function, reduced neuroinflammation and neuronal apoptosis, and enhanced microglial clearance of amyloid β. Cell experiments suggested these effects may relate to shifts in mitochondrial energy metabolism. The findings come from animal and in vitro work.
- Who or what was studied
- APP/PS1 mice modeling Alzheimer's disease, plus cultured microglia
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study used mice and cultured cells rather than humans, and the authors describe the mechanism as possibly related to metabolism rather than established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power density (irradiance)
- 20 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuroinflammation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.